Results 141 to 150 of about 121,208 (169)
Some of the next articles are maybe not open access.

Current knowledge into the role of the peptidylarginine deiminase (PAD) enzyme family in cardiovascular disease.

European Journal of Pharmacology, 2020
Peptidylarginine deiminase (PAD) family members have a vital role in maintaining the stability of the extracellular matrix (ECM) during remodelling in several heart diseases.
Doa’a Al-u’datt   +3 more
semanticscholar   +3 more sources

Biochemical Characterization of Peptidylarginine Deiminase-Like Orthologs From Thermotolerant Emericella Dentata and Aspergillus nidulans

Enzyme and Microbial Technology, 2019
Peptidylarginine deiminases (PADs) are a group of hydrolases, mediating the deimination of peptidylarginine residues into peptidyl-citrulline. Equivocal protein citrullination by PADs of fungal pathogens has a strong relation to the progression of ...
Mahmoud Sitohy   +2 more
exaly   +2 more sources

Structures of human peptidylarginine deiminase type III provide insights into substrate recognition and inhibitor design.

open access: yesArchives of Biochemistry and Biophysics, 2021
Peptidylarginine deiminase type III (PAD3) is an isozyme belonging to the PAD enzyme family that converts arginine to citrulline residue(s) within proteins. PAD3 is expressed in most differentiated keratinocytes of the epidermis and hair follicles, while
K. Funabashi   +10 more
semanticscholar   +2 more sources

Peptidylarginine Deiminase and Alzheimer’s Disease

Journal of Alzheimer's Disease, 2021
Peptidylarginine deiminases (PADs) are indispensable enzymes for post-translational modification of proteins, which can convert Arg residues on the surface of proteins to citrulline residues.
Lai Wang   +4 more
semanticscholar   +1 more source

A2.13 Ra-associated autoantibodies promote synovial fibroblast migration and adhesion through a peptidylarginine deiminases (pad) dependent pathway

Annals of the Rheumatic Diseases, 2016
Background and objectives We have recently demonstrated that anti-citrullinated proteins antibodies (ACPAs) promote IL-8 production and osteoclast activation. In a second step this might lead to chronic synovial inflammation characterised by activation of resident synovial fibroblasts (SF).
M Sun   +10 more
openaire   +1 more source

OP0298 Anti-Citrullinated Protein Antibodies Promote Synovial Fibroblasts Migration and Adhesion through A Peptidylarginine Deiminases (PAD) Dependent Pathway

Annals of the Rheumatic Diseases, 2016
Background Synovial fibroblasts (SFs) contribute to rheumatoid arthritis (RA) pathogenesis by growing into the synovial space and by producing pro-angiogenic and tissue remodelling factors, chemokines and inflammatory cytokines that recruit and stimulate various immune cells.
M. Sun   +10 more
openaire   +1 more source

Structural and mechanistic insights into peptidylarginine deiminase (PAD2/PAD4) mediated citrullination and therapeutic targeting: A review.

International Journal of Biological Macromolecules
Peptidylarginine deiminases are key regulators of chromatin remodeling, gene transcription, and immune responses, mediating the post-translational modification of various proteins.
F. Bashir   +7 more
semanticscholar   +1 more source

Citrullination of fibrinogen by peptidylarginine deiminase 2 impairs fibrin clot structure.

Clinica chimica acta; international journal of clinical chemistry, 2019
BACKGROUND Citrullination is the post-translational conversion of arginine into citrulline in proteins. The reaction is catalyzed by peptidylarginine deiminase (PAD), of which five isoforms exist.
T. Damiana   +6 more
semanticscholar   +1 more source

Identification of Roles for Peptidylarginine Deiminases (PADs) In Models of Nervous System Regeneration, Assessing Capacities of Pharmacological PAD Inhibitor Application

Human Peptidylarginine deiminases (PADs) comprise five isozymes (PAD1,2,3,4 and PAD6) performing citrullination (deimination) with distinct tissue localisation and target preferences. They are implicated in various inflammatory conditions, including those affecting the central nervous system (CNS). Although PAD2 and PAD4 are currently recognised as the
openaire   +1 more source

Current Knowledge Into the Role of the Peptidylarginine Deiminase (PAD) Enzyme Family in Cardiovascular Disease

European Journal of Pharmacology, 2021
Bruce G. Allen   +2 more
exaly  

Home - About - Disclaimer - Privacy